Composition Epirubicin (50mg)
Primary Use Breast cancer
cautionPotentially unsafe with Alcohol Lactation
Medicine Overview of Epixtra Injection
Uses of Epixtra Injection
Epixtra 50mg Injection is used in the treatment of breast cancer.
Epixtra Injection side effects
Side Effects of Epixtra are Rash, Vomiting, Weakness, Conjunctivitis, Nausea, Mouth sore, Hair loss, Absence of menstrual periods, Itching, Diarrhoea, Hot flashes.
How to use Epixtra Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Epixtra Injection works
Epixtra 50mg Injection is an anti-cancer medication. It works by suppressing the activity of an enzyme (topoisomerase II) involved in DNA multiplication of the breast cancer cells. It also forms harmful chemicals (free radicals) which cause DNA damage. This slows the growth of breast cancer cells and eventually kills them.
In Depth Information on Epixtra Injection
Expert advice for Epixtra Injection
- Use appropriate contraception during treatment with epirubicin, if you are women of childbearing potential.
- Male patients should not to father a child during and for 6 months after stopping epirubicin treatment.
- Inform you doctor if you have or had suffered problems with your heart, liver or if you have severe infection such as urinary infection.
- Do not drink fluids for 12 hours before the treatment if epirubicin is to be used in the bladder.
- Tell your doctor if you are or planning to become pregnant or are breastfeeding.
Epixtra Injection related warnings
Special precautions for Epixtra Injection
Taking Epirubicin together with alcohol may cause liver problems.
WEIGH RISKS VS BENEFITS
Epixtra 50mg Injection is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Epixtra 50mg Injection is unsafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable.
Do not drive unless you are feeling well. Epixtra 50mg Injection may cause episodes of nausea and vomiting, which can temporarily lead to an impairment of the ability to drive.
Epixtra 50mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Epixtra 50mg Injection may not be needed in these patients. Please consult your doctor. Lower doses may be considered in patients with serum creatinine > 5mg/dL.
Epixtra 50mg Injection should be used with caution in patients with liver disease. Dose adjustment of Epixtra 50mg Injection may be needed. Please consult your doctor. Use of Epixtra 50mg Injection is not recommended in patients with severe liver disease.